Extensive coronary calcification: A clinically unrecognised condition

Current Vascular Pharmacology

Volumn 8, Issue 5, 2010, Pages 701-705

  Nicoll, Rachel ^a,b   Henein, Michael ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b CANTERBURY CHRIST CHURCH UNIVERSITY   (United Kingdom)

Author keywords

Atheroma; Atherosclerosis; Biomineralisatio; Coronary calcification

Indexed keywords

CALCIUM; CORTICOSTEROID; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; PHOSPHATE; VITAMIN D; VITAMIN K GROUP; WARFARIN;

ALCOHOL ABUSE; AORTA VALVE DISEASE; ARTICLE; ATHEROGENIC DIET; ATHEROMA; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNICITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MACROPHAGE; MONCKEBERG MEDIAL CALCIFIC SCLEROSIS; MONOCYTE; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VITAMIN D DEFICIENCY; ANIMAL; ATHEROSCLEROTIC PLAQUE; BLOOD; CALCINOSIS; CARDIOMYOPATHY; DIET THERAPY; HOSPITALIZATION; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; CALCINOSIS; CARDIOMYOPATHIES; CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 78649913846     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016110792007003     Document Type: Article

References (86)

1. Zidan M, Nicoll R, Schmermund A, Henein MY. Cardiac multidetector CT: its unique contribution to cardiology practice. Int J Cardiol 2009; 132: 25-9.
2. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002; 39: 225-30.
3. Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 2005; 112: 572-7.
4. Shioi A, Nishizawa Y. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications. J Ren Nutr 2009; 19: 78-81.
5. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-76.
6. Shoi A, Taniwaki H, Jono S, et al. Mönckeberg's medial sclerosis and inorganic phosphate in uremia. Am J Kidney Dis 2001; (Suppl 1): 47-9.
7. Byts IUV, Holdobina VIE, Dudko MO. The current concepts of the pathogenesis of Monckeberg-type arteriosclerosis. Fiziol Zh 2000; 46: 64-72.
8. Nicholls SJ, Tuzcu EM, Wolski K, et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol 2007; 49: 263-70.
9. Feuerstein IM, Brazaitis MP, Zoltick JM, et al. Electron beam computed tomography screening of the coronary arteries: experience with 3,263 patients at Walter Reed Army Medical Center. Mil Med 2001; 166: 432-42.
10. Kronmal RA, McClelland RL, Detrano R, et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007; 115: 2722-30.
11. Efstratiadis G, Tziomalos K, Mikhailidis DP, Athyros VG, Hatzitolios A. Atherogenesis in renal patients: a model of vascular disease? Curr Vasc Pharmacol 2008; 6: 93-107.
12. Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. The effect of statins vs. untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atrovastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 57: 728-34.
13. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001; 31: 509-19.
14. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17: 680-7.
15. Aikawa E, Nahrendorf M, Figueiredo JL, et al. Osteogenesis associates with inflammation in early stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007; 116: 2841-50.
16. Tintut Y, Patel J, Parhami F, Demer LL. Tumour necrosis factoralpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-42.
17. Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macorphages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification. Circ Res 2005; 96: 1248-56.
18. Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL. High-density lipoprotein regulates calcification of vascular cells. Circ Res 2002; 91: 570-6.
19. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24: 1161-70.
20. Hoff JA, Chomka EV, Krainik AJ, Daviglus M, Rich S, Kondos GT. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol 2001; 87: 1335-9.
21. Demer L, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008; 117: 2938-48.
22. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 2002; 87: 1062-7.
23. Reaven PF, Sacks I. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia 2005; 48: 379-85.
24. Yoshitama T, Nakamura M, Tsunoda T, et al. Insulin resistance in nondiabetic patients is associated with expansive remodeling in coronary arterial lesions. Coron Artery Dis 2004; 15: 187-93.
25. Nasir K, Katz R, Takasu J. Ethnic differences between extracoronary measures on cardiac computed tomography: multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2008; 198: 104-114.
26. McRobb L, Handelsman DJ, Heather AK. Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endocrinology 2009; 150: 841-8.
27. Spasovski GB. Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 2007; 39: 1209-16.
28. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H. Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19; 2112-8.
29. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circulation Res 2006; 99: 1044-59.
30. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004; 286: E686-696.
31. Goldsmith D, Ritz E, Covic A. Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 2004; 66: 1315-33.
32. Anagnostis P, Kaeagiannis A, Kakfika AI, Tziomalos K, Athyros VG, Mikhailidis DP. Atherosclerosis and osteoporosis: agedependent degenerative processes or related entities? Osteoporos Int 2009; 20: 197-207.
33. Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H. Vascular calcification and osteoporosis form clinical observation towards molecular understanding. Osteoporos Int 2007; 18: 251-9.
34. Demer LL, Tintut Y. Mechanisms linking osteoporosis with cardiovascular calcification. Curr Osteoporos Rep 2009; 7: 42-46.
35. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994; 94: 1597-604.
36. Shea MK, Booth SL, Massaro JM, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008; 167: 313-20.
37. Rutsch F, Ruf N, Vaingankar S, et al. Mutations en ENPP1 are associated with 'ideopathic' infantile arterial calcification. Nat Genet 2003; 34: 379-81.
38. McClelland RL, Bild DE, Burke GL, et al. Alcohol and coronary artery calcium prevalence, incidence, and progression: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2003; 88: 1593-601.
39. Towler DA, Bidder M, Latifi T, Coleman T, Semenkovich CF. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receipt-deficient mice. J Biol Chem 1998; 273; 30427-34.
40. Kummerow FA. The negative effects of hydrogenated trans fats and what to do about them. Atherosclerosis 2009; 205: 458-65.
41. Park HA, Lee JS, Kuller LH. Relationship between premenopausal dietary intake and postmenopausal subclinical atherosclerosis. Atherosclerosis 2006; 186: 420-7.
42. Kummerow FA, Zhou Q, Mahfouz MM. Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am J Clin Nutr 1999; 75: 832-8.
43. Jono S, McKee MD, Murry CE. Posphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10E17.
44. Ito M, Cho BH, Kummerow FA. Effects of a dietary magnesium deficiency and excess vitamin D3 on swine coronary arteries. J Am Coll Nutr 1990; 9: 155-63.
45. Hsu HH, Culley NC. Effects of dietary calcium on atherosclerosis, aortic calcification, and icterus in rabbits fed a supplemental cholesterol diet. Lipids Health Dis 2006; 5: 16.
46. Nikolov IG, Mozar A, Drüeke TB, Massy ZA. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. Blood Purif 2009; 27: 350-9.
47. van Woudenbergh GJ, Vliegenthart R, van Rooij FJ, et al. Coffee consumption and coronary calcification: the Rotterdam Coronary Calcification Study. Arterioscler Thromb Vasc Biol 2008; 28: 1018-23.
48. Grases F, Sanchis P, Perello J, et al. Phytate reduces age-related cardiovascular calcification. Front Biosci 2008; 13: 7115-22.
49. Pasch A, Schaffner T, Huynh-Do U, et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 2008; 74: 1444-53.
50. Matias PJ, Ferreira C, Jorge C, et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 611-8.
51. Hsu JJ, Tintut Y, Demer LL. Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol 2008; 3: 1542-7.
52. Zitterman A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol 2007; 18: 41-6.
53. Hunt JL, Fairman R, Mitchell ME, et al. Bone formation in carotid plaques: a clinicopathological study. Stroke 2002; 33: 1214-9.
54. Shoppet M, Schroff RC, Hofbuaer LC, Shanahan CM. Exploring the biology of vascular calcification in chronic kidney disease: What's circulating? Kidney Int 2008; 73: 384-90.
55. Tintut Y, Patel K, Territo M, Saini T, Parhami F, Demer LL. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 2002; 105: 650-5.
56. Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models and the prospects for therapy. Med Res Rev 2001; 21: 274-301.
57. Jaffe IZ, Tintut Y, Brenna GN, Demer LL, Mendelsohn ME. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscl Thromb Vasc Biol 2007; 27: 799.
58. Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol 1997; 24: 415-9.
59. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000; 20: 317-7.
60. Schurgers LJ, Aebert H, Vermeer C, Bultmann B, Janzen J. Oral anti-coagulant treatment: friend or foe in cardiovascular disease. Blood 2004; 104: 3231-2.
61. Koos R, Mahnken AH, Mühlenbruch G, et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol 2005; 96: 747-9.
62. Cranenburg ECM, Schurgers LJ, Vermeer C. Vitamin K: The coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-5.
63. Ohsaki Y, Shirakawa H, Hiwatashi K, et al. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006; 70: 926-32.
64. Li J, Lin JC, Wang H, et al. Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci 2003; 23: 5816-26.
65. Ducy P. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000; 289: 1502-4.
66. Karsenty G. The central regulation of bone remodelling. Trends Endocrinol Metab 2000; 11: 437-9.
67. Shanahan CM, Cary NR, Metcalf JC, et al. High expression of genes for calcification-regarding proteins in human atherosclerotic plaques. J Clin Invest 1994; 93: 2393-402.
68. Detrano RC, Wong ND, Doherty TM, Shavelle R. Prognostic significance of coronary calcific deposits in asymptomatic high-risk subjects. Am J Med 1997; 102: 344-9.
69. Achenbach S, Nomayo A, Couturier G, et al. Relation between coronary calcium and 10-year risk scores in primary prevention patients. Am J Cardiol 2003; 92: 1471-5.
70. Ehara S, Naruko T, Shirai N, et al. Small coronary calcium deposits and elevated plasma levels of oxidised low density lipoprotein are characteristic of acute myocardial infarction. J Atheroscler Thromb 2008; 15: 75-81.
71. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001; 103: 1051-6.
72. Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Triallists (CTT) Collaborators. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-78.
73. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005; 46:166-72.
74. Houslay ES, Cowell SJ, Prescott RJ, et al.; Scottish Aortic Stenosis and Lipid Lowering Therapy, Impact on Regression Trial Investigators. Progressive coronary calcification despite intensive lipidlowering treatment: a randomised controlled trial. Heart 2006; 92:1207-12.
75. Raggi P, Davidson M, Callister TQ, et al. Aggressive vs. moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005; 112: 563-71.
76. Schmermund A, Achenbach S, Budde T, et al. Effect of intensive vs. standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 2006; 113: 427-37.
77. Terry JG, Carr JJ, Kouba EO, et al. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am J Cardiol 2007; 99: 1714-7.
78. Achenbach S, Ropers D, Pohle K, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification. Circulation 2002; 106: 1077-82.
79. Anand DV, Lim E, Darko D, et al. Determinants of progression of coronary artery calcification in type 2 diabetes. J Am Coll Cardiol 2007; 50: 2218-25.
80. Motro M, Kirwan BA, de Brouwer S, et al. Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy. Cardiology 2007; 107: 165-71.
81. Motro M, Shemesh J, Grossman E. Coronary benefits of calcium antagonist therapy for patients with hypertension. Curr Opin Cardiol 2001; 16: 349-55.
82. Athyros VG, Papageorgiou AA, Elisaf M, Mikhailidis DP; GREACE Study Collaborative Group. Statins and renal function in patients with diabetes mellitus. Curr Med Res Opin 2003; 19: 615-7.
83. Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Statins and cardiovascular events in patients with end-stage renal disease on haemodialysis. The AURORA results suggest the need for earlier intervention. Curr Vasc Pharmacol 2009; 7: 264-6.
84. Elkeles R. Computed tomography imaging, coronary calcium and atherosclerosis. Exp Rev Cardiovasc Ther 2008; 6: 1083-93.
85. Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get with the Guidelines. Am Heart J 2009; 157: 111-7.
86. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004; 291: 210-5.